Continued Peer Reviewer Representation Employment Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Lloyd W. Klein Content Reviewer ACCF Interventional Scientific Council Professor of Medicine Rush University Medical Center None None None None None None Harlan M. Krumholz Content Reviewer Yale University School of Medicine Harold H. Hines, Jr, Professor of Medicine and Epidemiology and Public Health United Healthcare (Scientific Advisory Board) None None None None None Frederick G. Kushner Content Reviewer ACCF/AHA Task Force on Practice Guidelines Tulane University Medical Center Clinical Professor; Heart Clinic of Louisiana Medical Director None None None None None None Shamir R. Mehta Content Reviewer Hamilton Health Sciences, General Division HGH McMaster Clinic Director, Coronary Care Unit Astellas AstraZeneca Bristol-Myers Squibb Eli Lilly Sanofi-aventis None None Bristol-Myers Squibb Sanofi-aventis None None Douglass A. Morrison Content Reviewer Yakima Heart Center Professor of Medicine, Radiology; Cardiac Cath Lab Director None None None None None None L. Kristin Newby Content Reviewer Duke University Medical Center Associate Professor of Clinical Medicine AstraZeneca Daiichi Sankyo GlaxoSmithKline Johnson & Johnson Novartis None None Amylin Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Regado Merck None None E. Magnus Ohman Content Reviewer ACCF/AHA Task Force on Practice Guidelines Duke University Medical Center, Department of Medicine, Division of Cardiovascular Medicine Professor of Medicine; Subspecialty Signature Care Director Program for Advanced Coronary Disease Director AstraZeneca Bristol-Myers Squibb Boehringer Ingelheim Gilead Sciences LipoScience Merck Pozen Hoffmann-La Roche Sanofi-aventis The Medicines Company WebMD Boehringer Ingelheim Gilead Sciences None Daiichi Sankyo Eli Lilly None None William A. Tansey III Content Reviewer Summit Medical Group None None None None None None This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant to this document. 